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Abstract 
Multimorbidity is a common occurrence among older adults and has significant 
ramifications on mental health. As depression is expected to become the top contributor 
to chronic disease burden, it is important to understand the effect of multimorbidity on 
depressive symptoms, and whether particular disease clusters are associated with 
increased depressive symptoms. The present study investigated whether chronic diseases 
clustered among an older adult population, and whether these clusters predicted 
depressive symptom severity.  Secondary analyses were performed using interview data 
from the National Social Life, Health, and Aging Project (NSHAP). Participants were 
Black, White, and Hispanic adults > 65 years of age (M=73.7, SD=5.7) who reported at 
least two chronic illness diagnoses (mean diagnoses = 3.1, SD = 1.2). Patterns of 
comorbidity were assessed using tetrachoric factor analysis and a multivariable linear 
regression model. Factor analysis demonstrated five disease patterns: cancers, arthritis, 
pulmonary, metabolic, and stress factors. Analyses demonstrated that the five factors 
were not predictive of increased depressive symptom severity. However, the total number 
of conditions was significantly associated with increased depressive symptomatology. 
This is likely due to the stress associated with chronic disease symptom management, and 
reflective of poor or unsuccessful disease management and symptom burden. These 
findings add to the limited body of knowledge investigating disease patterns in older 
adults, and help to better understand the reciprocal impact of chronic conditions on 
mental health.  




 Table of Contents  
Introduction  ........................................................................................................................ 1 
   Morbidity, Mortality, and Chronic Illnesses  ..................................................................  2 
   Mood Disorders and Chronic Illnesses  ..........................................................................  4 
Methods............................................................................................................................... 7 
Participants ...................................................................................................................... 7 
Measures ......................................................................................................................... 8 
Statistical Analyses ....................................................................................................... 10 
Results ............................................................................................................................... 13 
Participant Characteristics ............................................................................................ 13 
Prevalence Rates of Chronic Conditions and Multimorbidities ................................... 13 
Patterns of Multimorbidities in Older Adults ............................................................... 14 
Multimorbidity Patterns as Predictors of Depression in Older Adults ......................... 15 
Discussion ......................................................................................................................... 17 
Disease Patterns in Older Adults .................................................................................. 18 
Disease patterns and depressive symptoms .................................................................. 21 
Depression and disease management ............................................................................ 22 
Limitations .................................................................................................................... 25 
Future Directions .......................................................................................................... 27 
References ......................................................................................................................... 30 
Appendices ........................................................................................................................ 46	
1 
Do Disease Clusters Predict Depressive Symptoms in Older Adults? 
As a result of improvements in medical procedures and pharmacological 
treatments, conditions that were once considered fatal (e.g., congestive heart failure, 
chronic obstructive pulmonary disorder, diabetes) have become chronic, life-long 
conditions (Anderson & Horvath, 2004; Fortin, Lapointe, Hudon, Vanasse, Ntetu & 
Maltais, 2004; Garcia-Olmos et al., 2012). Termed “noncommunicable diseases (NCD),” 
these diseases are thought to be partially attributed to the general deterioration of the 
body with age, and thus adversely afflict older adults far more than younger adults 
(Benjamain, 2010; Bisschop, Kriegsman, Beekman & Deeg, 2004; CDC, 2016; Salive, 
2013). Commonly referred to as chronic illnesses or chronic diseases, the umbrella term 
“noncommunicable disease” encompasses conditions that are unable to be passed from 
person to person (CDC, 2016; World Health Organization [WHO], 2015) with both an 
extended duration (usually greater than six months) and slow progression (Bisschop et 
al., 2004; Islam, Yen, Valderas & McRae, 2014). Inherent to these disorders is a 
complex, multifactorial etiology, and the development is often attributed to multiple risk 
factors, including environment, genetics, socioeconomic status, and human behavior 
(Bisschop et al., 2014). Furthermore, chronic illnesses vary in symptomatology, with a 
presentation heterogeneous to both the disorder and the individual (Wolff, Starfield & 
Anderson, 2002). Noncommunicable illnesses often have a long latency period (that is, 
an extended duration of time between exposure to illness and outward display of 
symptoms), with little demonstrable change over time (Bisschop et al., 2004; Williams, 
1997).  
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Currently, the highest prevalence of chronic conditions is among older adults, 
with over 90% diagnosed with at least one disease (AARP, 2016; CDC, 2016). However, 
due to the etiology of chronic conditions, the diseases have a tendency to cluster, where 
the presence of one condition increases the likelihood of concurrently meeting criteria for 
another (Anderson & Horvath, 2004; Wolff et al., 2002). While the terms comorbidity 
and multimorbidity are often used interchangeably to describe the presence of two or 
more diseases, the operational definitions are quite distinct: 
Comorbidity refers to a combination of disorders in addition to an index disease, 
where an index condition is defined as condition that is thought to be the primary or main 
disorder of focus (Feinstein, 1970; Formiga et al., 2013; Mercer, Salisbury & Fortin, 
2014; Valderas, Starfield, Sibbald, Salisbury & Roland, 2009; van den Akker, Buntix & 
Knottnerus, 1996) (see Appendix A, Figure 1).  
Multimorbidity refers to the co-occurrence of two or more chronic or acute 
conditions without an identifiable index disease (Formiga et al., 2013; Richardson & 
Doster, 2014; van den Akker et al., 1996) (see Appendix A, Figure 2).  However, for the 
purpose of this paper and the following analyses (and as is consistent with the literature), 
the terms comorbidity and multimorbidity will be used interchangeably to describe 
situations in which individuals have more than one condition, as it is impossible to 
determine the presence of an identified index disease from the literature.  
Morbidity, mortality, and chronic illnesses 
Chronic illnesses are swiftly becoming a global health concern due to their 
significant association with elevated morbidity of additional diseases and mortality risk, 
as well as rising healthcare costs (Fisher & Ma, 2014). Global findings postulate that 
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greater than 60% of individuals suffer from comorbid chronic conditions, increasing to 
80% for individuals over the age of 85 (Salive, 2013; Wolff et al., 2002), and are the 
leading cause of premature death and disability worldwide (CDC, 2016; Hunter & Reddy, 
2013). Current estimates indicate that chronic illnesses account for roughly 1.7 million 
deaths each year in the United States alone (CDC, 2016; WHO, 2015). 
The prevalence of multimorbidities (both nationally and globally) is expected to 
rise – current estimates project that 81 million Americans alone will be diagnosed with 
comorbid conditions by 2020 (Anderson & Horvath, 2004; Anderson & Knickman, 2001; 
Bayliss, Steiner, Fernald, Crane & Main, 2003). While exact numbers vary, studies 
consistently find that 29% - 75% of older adults in the United States have been diagnosed 
with at least two chronic conditions (Anderson & Horvath, 2004; Bayliss et al., 2003; 
CDC, 2016; Fillenbaum, Pieper, Cohen, Cornoni-Huntley & Guralnik, 2000; Fisher & 
Ma, 2014; Fortin, Bravo, Hudon, Vanasse & Lapointe, 2005; Fortin et al., 2004; Fortin, 
Soubhi, Hudon, Bayliss & van den Akker, 2007; Ploeg et al., 2017; Schoenberg, Kim, 
Edwards & Fleming, 2007; Ward, Schiller & Goodman, 2014; Wolff et al., 2002), with 
up to 25% diagnosed with four or more (Wolff et al., 2002). 
Currently, most research focuses on single chronic conditions, which is quite 
limiting, and does not reflect complex realities, given the high prevalence rates of 
comorbid chronic conditions in older adults (Barnett et al., 2012; Vanfleteren et al., 
2013). Furthermore, the little existing data varies across studies regarding common co-
occurring conditions (Sinnige et al., 2013; van den Bussche et al., 2011). For example, a 
literature review conducted by Sinnige and colleagues (2013) found hypertension and 
diabetes to be frequently clustered individual conditions. However, a second study 
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conducted in 2011 found hypertension, lipid metabolism disorders, chronic low back 
pain, diabetes, osteoarthritis, and chronic ischemic heart disease to be the most frequently 
occurring individual diseases within the study population (van den Bussche et al., 2011). 
A third study illustrated a pattern of hypertension and diabetes, as well as hypertension 
and stroke, to be commonly disease combinations in older adults (Kirchberger et al., 
2012).  
Additionally, little information is available regarding common disease clusters, 
particularly in older adults (Marengoni et al., 2013; Marengoni, Rizzuto, Wang, Winblad 
& Fratiglioni, 2009). It is also unclear whether diseases cluster in a particular, predictable 
pattern (such as by body system, or according to health systems as defined by the WHO). 
The available literature broadly suggests a clustering among cardiovascular and 
metabolic disorders (Schafer et al., 2010; Sinnige et al., 2013; van den Bussche et al., 
2011), cardio-respiratory diseases (Garin et al., 2016), and musculoskeletal disorders 
(Prados-Torres et al., 2014); however, these clusters tend to differ by study population. 
The observed differences in the literature may be due to inherent differences in the 
sample populations, geographical location (Kirchberger et al., 2012; Schafer et al., 2010), 
focused on racial/ethnic groups (Garin et al., 2014) or differences in inclusion criteria or 
study design (Schafer et al., 2010). As such, more research is needed to better investigate 
common disease clusters among those with multimorbidities, particularly in the older 
adult population.  
Mood disorders and chronic illnesses 
Not only are chronic illnesses associated with prolonged physical health 
symptoms and disease burden, but also with long-term psychological effects (Benjamin, 
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2010; Cella, 1994; Cella & Stone, 2015; Cella & Tulsky, 1993; Gandek, Sinclair, 
Kosinski & Ware, 2004). Current estimates suggest that the rates of mental health 
conditions (largely mood and anxiety disorders) are increased by roughly 41% among 
those with chronic illnesses (Turvey & Klein, 2008); comorbidity rates of depression 
alone fall between 20-30% among this population (Turvey & Klein, 2008). Depression is 
thought to be an independent outcome of chronic conditions and may develop as a result 
of increased symptom burden and functional impairment associated with these complex 
medical conditions (Blazer, 2004; Ludman et al., 2004; Richardson, Russo, Lozano, 
McCauley & Katon, 2008).   
Depression has been cited as producing the greatest decrement in health status, 
and is expected to become one of the top contributors to chronic disease burden by 2020 
(Moussavi et al., 2007). When compared with healthy cohorts, individuals in psychiatric 
distress more frequently report medical symptoms and functional impairments, and rate 
their symptoms and impairments as more severe (Hays, Wells, Sherbourne, Rogers & 
Spritzer, 1995; Johnson, Weissman & Klerman, 1992; Kroenke et al., 1997; Ludman et 
al., 2004; Ornel, Vonkorff, Ustun, Pini, Korten & Oldehinkel, 1994; Spitzer et al., 1995; 
Sullivan, LaCroix, Spertus & Hecht, 2000). Additionally, psychiatric conditions may 
further complicate the medical presentation, as they are associated with physical 
disability and greater symptom burden (Earnshaw & Quinn, 2012; Ludman et al., 2004; 
Richardson et al., 2008, Rutledge et al., 2006). This relationship appears be bidirectional 
(Turvey & Klein, 2008).  
While an association exists between depression and increasing number of physical 
diseases (presented as a total sum) (Barnett et al., 2012; Gunn et al., 2012; Moussavi et 
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al., 2007), little information is available regarding the cumulative effect of 
multimorbidities on depressive symptoms. The literature is devoid of information 
investigating the effect of specific disease clusters on psychiatric well being, largely due 
to an inconclusive understanding of cluster patterns in older adults. With a better 
understanding of the impact of multimorbidities on depressive symptom severity, 
interventions and treatment plans can be better designed to improve overall health 
outcomes. Given the percentage of older adults who suffer from multimorbidities, in 
addition to the impact of depression on disease burden, it is crucial to understand the 
relationship among these variables.  Therefore, the aims of the present study are:  
1. To determine which chronic conditions cluster together most frequently 
2. To investigate the relationship among disease clusters and depressive symptom 
severity   
3. To better understand the psychosocial factors (gender, race/ethnicity, 
educational status, socioeconomic status, marital status) that impact the 





Parent project. Data for this study were obtained from the first wave of national 
longitudinal data collected by the National Social Life, Health, and Aging Project 
(NSHAP) from 2005 to 2006. The project is a population-based research study 
investigating health and social factors among community-dwelling older adults in the 
United States (Suzman, 2009). The parent study was designed to be a nationally 
representative probability sample of community-dwelling older adults born between 1920 
and 1957, aged 57-85, with an oversampling of African-Americans and Hispanics 
(O’Muircheartaigh, Eckman & Smith, 2009; Suzman, 2009). To identify individuals 
within this specific demographic, NSHAP partnered with the 2004 household-screening 
wave of the Health and Retirement Study (HRS), which was recruiting for a new cohort 
(Suzman, 2009), and purchased the sample of adults aged 57-85 years (Suzman, 2009).  
Using a classic multistage area probability sample design, households were identified for 
interviewing if they fell into one of three predetermined age groups (57 to 65; 66 to 74; 
75 to 84) of either gender (O’Muircheartaigh et al., 2009). Sample eligibility was defined 
based inclusively on year of birth (1920 – 1947) (O’Muircheartaigh et al., 2009). The 
final sample for this investigation included 3,005 individuals.  
Participants completed face-to-face interviews and a self-administered post-
interview (or a “leave-behind questionnaire”); the interview was completed in the 
individual’s home in either English or Spanish using a Computer-Assisted Personal 
Interview (CAPI) questionnaire (Smith et al., 2009). Interviews were conducted by field 
interviewers who completed an extensive and standardized training prior to 
commencement.  
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 Current project. For the purpose of this project, Wave 1 was selected for 
analysis, as it was determined to be the most complete dataset with variables related to 
chronic illnesses and mental health.  The sample population was restricted by age (65 – 
85 years), ethnicity (inclusive for those identifying as Caucasian, African-American or 
Hispanic Non-Black), and by disease diagnosis (including individuals with two or more 
diagnoses, as the current research is focused on multimorbidities), ending with a sample 
size of 1,371. This sample was inclusive for those identifying as Caucasian, African-
American or Hispanic Non-Black, as 98% of the sample identified as such. It was 
deemed that the remaining two percent would not lend itself to a meaningful comparison 
with the three larger groups, and was thus excluded from analyses.  
Measures 
Chronic condition diagnosis. Prevalence of chronic conditions was assessed via 
self-report. Each participant was asked, “Has a medical doctor ever told you that you 
have any of the following conditions?” Participants were then read a list of conditions, 
with the interviewer checking off each item endorsed. Conditions included arthritis, 
diabetes or high blood sugar, skin cancer, cancer other than skin cancer, high blood 
pressure or hypertension, and emphysema, chronic bronchitis, or chronic obstructive lung 
disease. Participants responded with a “yes” or “no.”  See Appendix A, Figure 3 for the 
full measure.  
Mental health variables. Depression symptomatology was measured using the 
11-item Iowa Short Form of the Center for Epidemiological Studies Scale (CES-D) 
(Cagney, Browning, Iveniuk & English, 2014; Payne, Hedberg, Kozloski, Dale & 
McClintock, 2014). The Iowa Short Form of the CES-D was developed in 1993 in efforts 
9 
to reduce response burden for participants (Carpenter et al., 1998). The scale includes 11 
of the original 20 items and collapses the two highest response categories (Carpenter et 
al., 1998). Factor analyses demonstrated this form maintained the same four-factor 
solution as the original form (Carpenter et al., 1998; Radloff, 1997). Reliability analyses 
showed good internal consistency (α = 0.81), and scores were highly correlated with 
those from the original version (rs > 0.83) (Carpenter et al., 1998). 
Respondents were asked how often in the past week they experienced thoughts 
and feelings consistent with depressive symptoms (see Appendix A, Figure 4 for full 
measure). Responses were presented in a 4 point scale ranging from “Rarely or none of 
the time,” “Some of the time,” “Occasionally,” and “Most of the time.” The two highest 
response options were collapsed (“Occasionally” and “Most of the time”) into “Much or 
most of the time,” to correspond most closely with the 11-item Iowa short form scale.  
Individuals who answered “Don’t Know” or “Refused” were excluded from analyses.  
Further calculations were conducted to determine the overall CES-D score, which 
indicates depressive symptom severity. The three response categories (“Rarely or none of 
the time”, “Some of the time”, and “Much or most of the time”) were coded as 0, 1 or 2, 
respectively. The scores were then summed across the 11 elements to produce a total 
score ranging from 0-22, with higher scores indicating greater depressive 
symptomatology.  
Sociodemographic variables. Sociodemographic factors used in analysis include 
age, sex, race/ethnicity, marital status, education, and household income. Age is 
presented as a continuous variable, calculated from the participant’s reported date of birth 
and ranging from 65 to 85. Gender, ethnicity, marital status, education and household 
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income were self-reported. For analysis, race/ethnicity was categorized into three groups: 
Non-Hispanic White, Non-Hispanic Black, and Hispanic Non-Black. Education was 
categorized as: less than high school, high school degree or equivalent, vocational 
certificate/some college/associate’s degree, and Bachelor’s degree or higher.  Marital 
status was assessed by asking participants to indicate whether they were married, living 
with a partner, divorced, separated, widowed, or never married. Participants who 
endorsed being separated, divorced, widowed or never married were asked, “Do you 
currently have a romantic, intimate, or sexual partner?” with possible responses “yes” or 
“no.” Combined responses from these two questions will be dichotomized into a 
partnership variable, where individuals who endorsed married or living with a partner are 
dichotomized to “yes.” Household income was a continuous variable, where individuals 
reported their approximate household income for the last year.  
Statistical Analyses 
Descriptive analyses were calculated using means and frequencies. Differences in 
sociodemographic variables, prevalence rates of conditions, and number of 
multimorbidities were calculated across race using a Chi-square test and analysis of 
variance test. Analyses were conducted in R 3.3.3 (R Core Team, 2017) using the Psych 
package (Revelle, 2017). 
An exploratory factor analysis was applied to determine the disease clusters. This 
method identifies groups of correlated diseases (i.e., factors) with an underlying common 
causal trait. Additionally, this method allows for diseases to be included in multiple 
simultaneous factors. As is consistent with previous studies (Garin et al., 2014; 
Kirchberger et al., 2012; Schafer et al., 2010), a tetrachoric matrix was utilized to account 
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for the presentation of diseases as binary variables (1 = disease present, 0 = disease not 
present). This assumes that the diseases have an underlying, continuous characteristic 
(i.e., the diseases are progressive) (Prados-Torres et al., 2012). The factors were extracted 
using the ordinary least squares method, and the number of factors was determined using 
parallel analysis. Parallel analysis compares the factor scree of the observed data with 
that of a similar sized simulated random matrix to determine the number of factors 
appropriate for extraction (Revelle, 2017). An oblique (Oblimin) rotation was applied for 
easier interpretation of the results. To determine the adequacy of the sample, a Kaiser-
Meyer-Olkin (KMO) test was conducted. This measurement provides values between 
zero and one, where values closer to one indicate a greater goodness of fit. Additionally, 
the proportion of cumulative variance was obtained to provide the variance as explained 
by each factor (Garin et al., 2014; Poblador-Plou et al., 2014; Prados-Torres et al., 2012). 
Factors with loadings >0.25 were selected, as is consistent with previous studies (Garin et 
al., 2014; Kirchberger et al., 2012; Schafer et al., 2010). As multimorbidity is defined as 
the presence of two or more conditions, individuals were determined to have a specific 
disease pattern if they presented with at least two disorders that comprised the cluster.  
As CES-D scores were positively skewed, a base ten logarithmic transformation 
was utilized, resulting in a normal distribution of scores. Given the body of literature 
implicating depression as an outcome of chronic illnesses, depressive symptom severity 
was determined to be the variable of interest in this study (Blazer, 2004; Ludman et al., 
2004; Richardson, Russo, Lozano, McCauley & Katon, 2008; Simon, 2001).  As such, 
multivariate linear regression models were calculated to investigate the relationship 
among disease clusters and depressive symptom severity, while adjusting for 
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 Of the 1,371 participants analyzed, the majority identified as non-Hispanic 
White/Caucasian and female, with a mean age of 73.9 (SD = 5.7) years. More than half of 
the sample was married or living with a partner. Statistically significant differences were 
observed when comparing race/ethnicity with regard to marital status, education, and 
income. Black participants were less likely to be married, and reported significantly 
lower income, while Hispanic participants reported the lowest educational attainment. 
Additional sociodemographic characteristics are provided in Table 1 (Appendix B).  
Significant differences were also observed across race/ethnicity regarding 
depressive symptom severity (p = <0.001), with Hispanic participants reporting the most 
severe depressive symptoms (Appendix B, Table 2).   
Prevalence Rates of Chronic Conditions and Multimorbidities 
Participants reported being diagnosed with an average of three (M = 3.1, SD = 
1.2) medical conditions (Appendix B, Table 3). While the sample only included 
participants endorsing two or more health conditions, nearly a third were diagnosed with 
four or more. Racial groups did not differ with respect to the total number of diagnosed 
conditions.  
Arthritis, hypertension, and cancers were found to be the most frequently 
occurring diseases in the overall study population (Appendix B, Table 4). Data showed 
that arthritis was the most frequently endorsed chronic illness. Cancers, 
emphysema/chronic bronchitis/COPD, and thyroid problems were significantly more 
common among White participants; Black and Hispanic participants reported 
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significantly higher rates of both diabetes and hypertension. Additionally, stroke and poor 
kidney function were significantly more prevalent among Black participants.  
Patterns of Multimorbidities in Older Adults 
Four factors were selected based on both the parallel analysis and scree plot. Per 
established guidelines, the KMO measure (KMO = 0.52) indicated a “miserable” 
sampling adequacy for factor analysis; this is likely due to low correlations among the 
diseases in the dataset. The final model demonstrated a Tucker Lewis Index of factoring 
reliability (TLI = 0.997) and the RMSEA index (0.009, CI = 0, 0.037), suggesting the 
final model was a very good fit for the dataset, accounting for a cumulative variance of 
40%. Arthritis was found to have negative loadings on each factor, and was subsequently 
placed into the regression model as an independent predictor variable. Leukemia, 
lymphoma, skin cancer, and other cancers were compiled into a single cancer diagnosis, 
which comprised the fourth factor (cancer factor).The third factor included emphysema 
or COPD and asthma (pulmonary factor).  The fourth factor included hypertension and 
diabetes (metabolic factor). Ulcers and stroke comprised the fifth factor (stress factor). 
Alzheimer’s disease, cirrhosis, and poor kidney function were excluded from the factor 
analysis, given their low prevalence rates in the sample (one, one, and seven percent, 
respectively). Thyroid problems were also excluded from the factor analysis due to the 
corresponding low TLI factoring reliability estimate. Table 5 illustrates the factor 
loadings for each condition.  
Among the total sample, approximately half (49.5%) was assigned to one disease 
pattern, 34.9% to two, and 7.1% to three or more. Only nine percent of participants could 
not be assigned to any of these disease patterns.  
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Multimorbidity Patterns as Predictors of Depression in Older Adults  
A series of hierarchical regression models were conducted to investigate the 
degree to which patterns of multimorbidities predict severity of depressive 
symptomatology (as measured by the CES-D), above and beyond that of 
sociodemographics. Variables were entered into the model in two steps: the first step 
included the sociodemographic variables as independent predictors (age, gender, 
race/ethnicity, marital status, income, and education). The second step included both 
sociodemographic variables and the multimorbidity disease patterns as determined by the 
factor analysis.  
Table 6 (Appendix B) shows the results from the hierarchical regression models, 
investigating the predictive power of sociodemographic variables and multimorbidity 
patterns with respect to depressive symptom severity. The first model demonstrated 
race/ethnicity to be significantly predictive of greater depressive symptom severity. 
Marital status, higher education, and greater income were significantly predictive of 
lower symptom severity.  
The second regression analysis (Model 2) included only factors determined by the 
factor analysis (arthritis, cancer, pulmonary, metabolic, and stress factors), adjusting for 
sociodemographic variables. This model finds the presence of arthritis (p = 0.003), the 
pulmonary factor (asthma and emphysema or COPD, p = 0.003), and the stress factor 
(ulcers and stroke, p = 0.008) to be significantly predictive of increased depressive 
symptom severity. A significant change in variance was observed after the inclusion of 
disease factors as predictors when compared with baseline sociodemographics (∆R2 = 
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0.015, p < 0.001), suggesting that disease diagnoses accounted for 2% more of the 
variance observed in CES-D total scores above the sociodemographic predictors.    
A third regression analysis (Model 3) was conducted including predictors from 
Model 2, as well as the diseases of which the factors were comprised to account for 
baseline disease effect. This was done to determine whether the associated factors 
contributed to the increase in depressive symptom severity, above and beyond the impact 
of each individual disorder. The inclusion of additional diseases reduced the estimates for 
the individual factors found to be significant predictors in the previous model. After 
adjusting for all predictors in a simultaneous model, arthritis, cancers, stroke, emphysema 
or COPD, and asthma were all found to be significantly associated with increased CES-D 
scores. A significant change in variance was observed when comparing Model 2 and 
Model 3 (∆R2 = 0.017, p < 0.001). Furthermore, a significant change in variance was 
observed with the increase inclusion of additional diseases as predictors when compared 
with Model 1 (∆R2 = 0.032, p < 0.001).  
A fourth regression analysis (Model 4) was conducted utilizing the predictors in 
the previous model (Model 3), as well as the remaining conditions (poor kidney function, 
thyroid problems, cirrhosis, and Alzheimer’s/dementia, i.e., those not included in the 
factor analysis). This inclusion led to a significant increase in variance when comparing 
Model 4 with Model 3 (∆R2 = 0.006, p < 0.001. This suggests that the inclusion of all 
diseases as predictor variables accounts for a 4% increase in the variance of depressive 





The current project contributes to the limited information available regarding 
disease clusters in older adults, particularly regarding the effect of multimorbidities on 
depressive symptom severity. Given the high rate of comorbidity and multimorbidity in 
this population, our findings help to better identify diseases that often occur 
simultaneously, which may in turn affect mental health outcomes.  
Results showed that significant differences existed across race/ethnic groups 
regarding depressive symptom severity as measured by the CES-D, with Hispanic 
individuals endorsing the most severe depressive symptoms. This is consistent with the 
available literature (Gonzalez, Tarraf, Whitfield & Vega, 2010), indicating a higher 
prevalence of mood disorders among Hispanic and Black older adults.   
Significant differences were also observed across race/ethnic groups with respect 
to specific medical conditions. Diabetes and hypertension were found to be significantly 
higher among Blacks and Hispanics. These conditions are more prevalent among 
minority individuals and are inversely associated with socioeconomic standing (Joshy et 
al., 2009), compounded by risk factors such as obesity, physical inactivity, tobacco use, 
and diet. These findings are further supported by the discrepancy observed when 
comparing income across race/ethnicity, as Blacks and Hispanics reported significantly 
lower incomes.  
Blacks were also noted to have a higher prevalence of poor kidney function, 
which is consistent with current literature indicating a threefold increased risk among 
Black individuals (National Kidney Foundation, 2016). Kidney failure is often a direct 
consequence of diabetes and hypertension; hypertension leads to increased pressure in the 
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blood vessels, which can lead to blockage resulting in kidney failure (Joslin Diabetes 
Center, 2017). Additionally, high levels of cholesterol and blood sugar can impair 
vessels, both of which are seen in individuals with diabetes (Joslin Diabetes Center, 
2017). Both diabetes and hypertension demonstrated significant elevations in this 
population; as such, the significant occurrence of poor kidney function is likely related to 
these two diseases. Additionally, similar to other conditions, kidney disease is impacted 
by sociodemographic factors such as obesity, physical inactivity, diet, access to 
resources, and adequate care.  
White participants endorsed a higher prevalence of cancers, which was largely 
driven by skin cancer and other unknown types of cancers. Whites are more likely to 
suffer from skin cancer due to the pigment of the skin – darker skin produces more 
melanin, which helps protect the skin from ultraviolet radiation (Buster, You, Fouad & 
Elmets, 2012; Linos et al., 2009; Skin Cancer Foundation, 2016). Interestingly, skin 
cancer is more prevalent among those from higher socioeconomic statuses. Individuals 
from more affluent backgrounds may participate in more outdoor leisure activities such 
as gardening, exercise, or playing sports, thus increasing their contact with harmful 
ultraviolet rays (Hausauer, Swetter, Cockburn & Clarke, 2011). Furthermore, White 
individuals are more likely to seek out medical attention and receive specialty care; as a 
result, cancer tends to be discovered sooner and at earlier staging. These findings may be 
reflective of those who have both access to resources (medical and financial) and have 
sought medical care (Cook et al., 2013; Welch et al., 2005).  
Disease Patterns in Older Adults 
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  The factor analysis portion of this study revealed four patterns of multimorbidities 
in a representative sample of individuals 65 years and older. The first pattern of 
multimorbidities, “pulmonary,” was comprised of emphysema, chronic bronchitis, or 
COPD, as well as asthma.  Despite their differing pathophysiology, asthma and COPD 
often occur simultaneously, forming a condition known as overlap syndrome (Bell & 
Busse, 2015; Soriano et al., 2003). As more than 40% of individuals diagnosed with 
COPD have a history of asthma, asthma has been cited as a potential risk factor for the 
development of COPD (de Marco et al., 2013; Diaz-Guzman, Khosravi & Mannino, 
2011). Asthma, emphysema, and COPD are the most common obstructive lung diseases 
(Diaz-Guzman et al., 2011; Soriano et al., 2003), and their prevalence increases with age 
(Diaz-Guzman et al., 2011). Given the overlap among these conditions, as well as the 
body systems implicated, it is possible that impairment in one part of the pulmonary 
system leads to increased risk for impairment in another, thus contributing to the findings 
of overlap syndrome.  
The second pattern, termed “metabolic,” included hypertension and diabetes. 
Hypertension is found twice as often in those diagnosed with diabetes (Barnett, 1994; 
Sowers, Epstein & Frohlich, 2001). While estimates vary, studies suggest that 20-70% of 
individuals with diabetes concurrently have hypertension, a combination likely due to 
underlying obesity or endothelial dysfunction (defined as an imbalance of the factors 
involved in the constriction and relaxation of the endothelium, which contributes to 
hypertension and diabetes, among other conditions) (Deanfield et al., 2005; Deedwania, 
2000; Kaplan, 2002). Furthermore, the presence of one disease exacerbates the other 
(Sowers et al., 2001), and hypertensive diabetic patients often suffer from increased 
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diabetic-related complications, such as retinopathy or nephropathy (American Diabetes 
Association, 2017).  
The third multimorbidity pattern, “stress,” was comprised of stroke and ulcers. 
Research has found a correlation between stroke and pressure ulcers, possibly related to 
undernourishment secondary to eating difficulties following a stroke (Ek, 1987; 
Suttipong & Sindhu, 2012; Westergren et al., 2001). Other factors contributing to 
pressure ulcers post-stroke include decreased mobility, impaired functional status, and 
difficulty conducting activities of daily living (Lindgren, Unosson, Fredrikson & Ek, 
2004; Suttipong & Sindu, 2012; Westergren et al., 2001). However, as it is unclear the 
type of ulcers experienced by individuals within this study population, it is impossible to 
state whether these findings are consistent with previous research. It could also be, 
perhaps, that both are associated with stress and chronic activation of the hypothalamic-
pituitary-adrenal axis (HPA axis). Older adults experience a number of significant life 
changes that accompany the aging process that can lead to increased stress (e.g., 
retirement, death of a spouse or loved one, inability to participate in activities that were 
previously enjoyed). Chronic stress has been demonstrated to have gastrointestinal 
effects, and can lead to the onset or exacerbation of chronic digestive disorders (Mayer, 
2000). Furthermore, increased and sustained activation of the HPA axis (created by 
elevated levels of cortisol due to stress) has been implicated in acute stroke (Fassbender 
et al., 1994). This disease factor may be indicative of poor coping mechanisms among 
these individuals, and may warrant further investigation as a possible area of intervention 
in the future.  
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Lastly, the fourth pattern, “cancers,” included skin cancer, leukemia, lymphoma, 
and other types of cancers not defined by the initial researchers. These conditions were 
combined into a single group prior to analyses, and were not found to load 
simultaneously with other factors. This is likely due to the varying types of cancers in this 
group, as they are quite unique and impact the body in differing ways. Cancer is 
characterized by uncontrollable division dispersion of cells into the surrounding tissue 
(National Cancer Institute, 2015), and affects the body in a detrimental manner unique to 
this disease category. As such, the biological uniqueness of this disorder may explain the 
singular loading on the fourth factor.  
Disease patterns and depressive symptoms 
While the observed factors were initially predictive of increased depressive 
severity, the significance was eliminated with the inclusion of additional conditions and 
diseases. However, the total number of conditions was predictive of increased depressive 
symptom severity (Table 7). This is consistent with current literature, suggesting that 
incidence of depression increases with number of chronic illnesses (Barnett et al., 2012; 
Gunn et al., 2012; Moussavi et al., 2007). These findings may be reflective of participants 
who struggle to successfully manage their chronic conditions. It may be that symptom 
severity is driven not by particular disease clusters, nor is it a reflection of the interaction 
between specific diseases and mental health, but rather the effort that is required to 
successfully manage multiple chronic diseases. Individuals with an increasing number of 
physical health conditions may experience depressive symptoms if they are burdened by 
the effort necessary to manage these diseases and have not established effective coping 
strategies to mitigate this stress. It is possible that, for certain individuals, once a disease 
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threshold is met, the depressive symptoms that occur are irrespective of the types of 
diseases, but are reflective of the combination of ailments with which the individual is 
struggling.   
Part of the stress that accompanies chronic diseases is learning to effectively 
manage the symptoms and slow the disease progression. Treatment for chronic conditions 
is heavily based on self-management, which requires time, effort, and motivation 
(Harrison et al., 2012); for example, insulin-dependent diabetes involves the 
administration of insulin, as well as proper management of blood sugar levels. For older 
adults with multimorbidities, resources (physical, emotional, and cognitive) to engage in 
treatment may be limited or insufficient. Furthermore, self-management is reliant upon a 
high level of cognitive capacity – for those with cognitive deficits, this may be difficult or 
impossible. Given the degree of self-management, as well as the burden associated with 
chronic conditions (Barnett et al., 2012; Benjamin, 2010; Chan & Corvin, 2016; Gunn et 
al., 2012; Harrison et al., 2012), it is postulated that the reported depressive symptom 
severity as seen in this study is driven by the stress associated with coping with 
multimorbidities.  
Depression and disease management 
Research has illustrated a strong correlation, as well as potential causal 
relationship, between chronic illnesses and depression, particularly with multimorbidities. 
Depression is thought to be an independent outcome of chronic illnesses and may 
develop as a result of increased symptom burden, disease management, and functional 
impairment associated with these complex medical conditions (Blazer, 2004; Ludman et 
al., 2004; Richardson et al., 2008).  Individuals with chronic diseases consistently report a 
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decreased quality of life (Benjamin, 2010; DuGoff, Canudas-Romo, Buttorff, Leff, & 
Anderson, 2014; Fortin et al., 2004; Kroenke, Jackson & Chamberlin, 1997; Ludman et 
al. 2004; Salive, 2013), driven largely by disability, loss of independence, and rapid 
declines in health (Earnshaw & Quinn, 2012; Fortin et al., 2004; Salive, 2013; Violan et 
al., 2014; Verbunt et al., 2005; Wolff et al., 2002). Additionally, medication usage may 
play a role in the onset of depressive symptomatology. A study conducted in 2005 found 
87% of Americans 65 years or older reported taking prescription medications daily 
(AARP, 2005). Of this population, individuals reported taking an average of four 
medications a day (AARP, 2005). Unfortunately, medications used to treat chronic 
illnesses (e.g., cancer medications, beta blockers, corticosteroids, gastrointestinal and 
respiratory medications) often have negative mood side effects (Alexopoulos, 2005; 
Djernes, 2006; Fiske et al., 2009), and may contribute heavily to depressive 
symptomatology.  
Further challenges associated with multimorbidities involve the treatment of these 
disorders - older adults with multiple chronic conditions are often under the care of 
multiple different providers. Medical management is complicated and requires substantial 
coordination. Proper care coordination among specialties is, unfortunately, often 
unsuccessful, as physicians may fail to communicate with (or be aware of) other 
specialists, may be uninformed of the medication and care regimens provided by other 
specialists, and/or may recommend conflicting or contraindicated treatments (Peikes, 
Chen, Schore & Brown, 2009; Pham et al., 2007). Participants who report higher 
depressive symptom severity may also have greater difficulties coordinating and 
receiving adequate care.  
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Furthermore, depression management may be overlooked in individuals with 
multiple chronic conditions, as attention may be focused on the physical health 
conditions given their chronicity and complexity (Nutting, Rost, Smith, Werner & Elliot, 
2000; Rost et al., 2000; Vyas & Sambamoorthi, 2011). Older adults are more likely to 
seek mental health treatment from their primary care providers (Fiske, Wetherell & Gatz, 
2009), where time and resources are limited. In this setting, depression symptoms 
compete with other ongoing medical concerns, and may be considered less urgent given 
physician time constraints (Nutting et al., 2000). Additionally, few clinicians are trained 
to detect depression in older adults, and many incorrectly attribute worsening mood 
symptoms to the aging process. Therefore, it is possible that the symptoms seen in this 
population are heavily impacted by the competing demands of their other physical health 
conditions, and little attention is granted to the alleviation of these symptoms. 
A number of other factors impact the care and disease management for older 
adults. Older adults have smaller social networks than younger adults (Fiori, Antonucci & 
Cortina, 2008), which may have detrimental effects on mental health. Introverted older 
adults have even smaller social networks, reducing the amount of social support at their 
disposal. Spouses or caregivers can be crucial in assisting in disease management, 
particularly with respect to coordinating care among specialists; those without this 
support may struggle to manage these activities on their own. It is therefore possible that 
participants endorsing increased mood symptoms have limited social supports and endure 
more social isolation.  
For those without easy access to transportation, attending a variety of 
appointments or obtaining medications may be a challenge. Older adults may lose the 
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ability to drive safely; for many, this leads to a greater reliance on family members, 
friends, or public transportation to attend medical appointments. Coordinating care is 
further impacted by transportation challenges, and older adults may question the 
necessity of attending an appointment if they are unable to secure safe transportation. 
Driving cessation has been demonstrated to heavily impact quality of life, as activities 
that were once conducted seamlessly now require increased coordination and reliance on 
others (Fonda, Wallace & Herzog, 2001).  
Older adults experience a series of personal losses that impact overall mental 
health. They experience the loss of loved ones, difficulty or inability to conduct activities 
independently, increased reliance on others, and worsening health. For those with 
multimorbidities, these are further compounded by disease progression that heavily 
impacts senescence. It is therefore postulated that the findings of this study reflect a 
difficulty coping and conducting disease management that is related to the total number 
of diagnosed conditions and irrespective of the type of chronic illness with which an 
individual is diagnosed.  
Limitations 
This study has several limitations. The study utilized a cross-sectional design, and 
as such, no causal relationships may be inferred among disease factors. Furthermore, 
disease conditions were assessed based on occurrence – no information is available 
regarding age at onset, length of occurrence, or severity. This information was gathered 
via self-report, and no further medical tests or documentation were required to confirm 
this diagnosis. The data also does not address whether these conditions are co-morbid or 
26 
multimorbid, nor does it indicate whether depressive symptomatology began prior to or 
after the onset of chronic illnesses.  
Statistical analyses revealed little correlation among the diseases within this 
sample. This is driving the low sampling adequacy seen with the KMO test. This is likely 
due, in part, to the types of conditions available for endorsement, as well as the 
population selected for the sample. Given this finding, factor analysis is not the best 
method for analyzing patterns of disease relationships with a nationally representative 
heterogeneous sample of older adults.  It is suggested that future studies should consider 
the possible limitations of this type of analysis when conducting research among this 
subset of the population. 
As the study was a secondary data analysis, there was little control over the 
format of the variables, particularly with respect to the health conditions. For example, 
COPD, chronic bronchitis, and emphysema are grouped into one variable, making it 
impossible to determine the portion of individuals diagnosed with any or all of these 
conditions. Specific cancer prompts included lymphoma, leukemia, and skin cancer; all 
other forms of cancer were condensed into an “other” category, thus diminishing the 
biological differences inherent to these diseases. If the “other cancers” category had been 
further broken down, it may have been possible to determine whether cancers also 
factored by body system, as was seen with the cardiorespiratory and metabolic factors, or 
whether specific types of cancers factored with other health conditions. Furthermore, 
incidence rates of cancer types differ by racial/ethnic group and sex, a distinction that is 
impossible to observe with the grouping of these variables. Mental health conditions, 
such as depression and anxiety, were also notably absent from the available list of 
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diseases, despite current findings suggesting that greater than 20% of older adults suffers 
from mental illness (CDC, 2008).  
As has been indicated in previous research (Garin et al., 2014; Kirchberger et al., 
2012), the external validity of these findings is limited, as studies have consistently used 
different numbers and types of conditions, which ultimately affects the observed 
factoring pattern. The overarching study of multimorbidities would benefit from an 
established standard for assessment across study populations (Kirchberger et al., 2012), 
which would strongly increase the generalizability of the findings.    
Future Directions 
 The results of this study contribute to the existing body of knowledge striving to 
understand disease patterns in older adults. This study additionally incorporates the usage 
of depression symptomatology, and attempts to better understand the factors (both 
sociodemographic and physiological) that are contributing to increased depression 
severity in the geriatric population. Further research is needed to establish an 
international standard for assessing multimorbidity across disciplines, including a set 
group of conditions to be included in analysis. By doing so, studies can be compared 
more seamlessly across populations, ethnicities, and demographics, increasing the overall 
understanding regarding disease patterns, especially among older adults. Creating a 
mechanism for better understanding disease patterns and clusters will likely lead to a 
more thorough and comprehensive understanding of the factors perpetuating the actual 
diseases, as well as subsequent health outcomes across domains.  
 Future research is also needed pertaining to the effect of medications on both 
multiple chronic conditions and depressive symptomatology. As this study did not 
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investigate the role of medications or medication side effects, it is unclear the extent to 
which they may be impacting depressive outcomes. Medications utilized to treat chronic 
conditions (e.g., beta blockers, gastrointestinal or respiratory medications, some cancer 
medications) often have negative mood effects and may cause depression (Alexopoulos, 
2005; Djernes, 2006; Fiske et al., 2009). Therefore, future research is warranted to 
explore this relationship and better understand the etiology of depressive symptoms in the 
chronically ill population.  
The clinical implications of this research are primarily related to the impact on 
treatment intervention both regarding the physical/medical and mental health aspects of 
care of older patients. A better understanding of the complex dynamic both among and 
between chronic conditions can help guide treatment for those with overlapping 
conditions. This information can be utilized to better coordinate care, particularly among 
differing specialties. Furthermore, it is crucial to comprehend the relationship between 
depression and the cluster of multiple chronic conditions, as depression can negatively 
impact disease outcomes (Earnshaw & Quinn, 2012; Ludman et al., 2004; Moussavi et 
al., 2007; Richardson et al., 2008, Rutledge et al., 2006). Understanding disease patterns 
with respect to mental health will help healthcare providers to better assess and care for 
the depressive symptomatology that is so common among the chronically ill population.  
 Additionally, increased psychoeducation regarding disease courses and patterns 
can foster patient autonomy, thus allowing older adults to feel more involved in their care 
and care decisions and better able to handle their own disease management. It is possible 
that a better understanding of these conditions, and subsequently improved treatment 
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regimens, will lead to improvements in life quality for older adults, with positive impacts 
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Figure 1. Conceptual diagram of comorbidity (Mercer, Salisbury & Fortin, 2014). This 
facilitates the understanding of comorbid conditions. 
 
	Figure 2. Conceptual diagram of multimorbidity (Mercer, Salisbury & Fortin, 2014). This 






Figure 3. Medical condition self report. This self-report questionnaire was used to 








Now let’s talk about thoughts and feelings you may have had during the past week. I will 
read a series of statements. Tell me how often during the past week you felt like this; rarely 
or none of the time, some of the time, occasionally, or most of the time? Don’t take too long 
over your replies; your immediate reaction to each item will probably be more accurate than 
a long thought out response. During the past week …	
Figure 4. Center for Epidemiological Studies Depression Scale, Iowa 11-item Short 
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<0.001*** 






(44,308.29)   
*p < 0.05; **p < 0.01; ***p < 0.001 





Incidence of Depressive Symptoms 
Race/Ethnicity CES-D Mean (SD) p-value 
White/Caucasian 16.78 (4.99) <0.001*** 
Black 17.88 (5.45) 
 Hispanic 19.21 (6.61) 
 *p < 0.05; **p < 0.01; ***p < 0.001 
 




Disease Prevalence Rates 
Diseases 














dementia 1.31 1.19 1.20 1.83 0.85 
Arthritis 71.19 70.14 76.31 67.89 0.12 
Asthma 13.06 13.19 11.24 14.68 0.61 
Cancers 36.54 44.74 13.25 14.68 <0.001*** 
Leukemia 0.73 0.89 0.40 0.00 0.46 
Lymphoma 1.31 1.49 0.40 1.83 0.36 
Skin cancer 22.32 29.66 0.00 6.42 <0.001*** 
Other cancers 17.72 20.14 12.45 7.34 <0.001*** 
Cirrhosis 1.17 1.29 1.20 0.00 0.49 
Diabetes 29.76 24.50 42.57 49.54 <0.001*** 
Emphysema, COPD, or 
chronic bronchitis 16.48 18.55 8.43 14.68 <0.001*** 
Hypertension 75.35 71.23 88.35 82.57 <0.001*** 
Poor kidney function 6.78 5.95 10.44 5.50 0.04* 
Stroke 13.86 14.09 16.87 3.67 0.003** 
Thyroid problems 21.59 24.31 12.45 15.60 <0.001*** 
Ulcers 19.77 19.84 16.87 25.69 0.16 
*p < 0.05; **p < 0.01; ***p < 0.001 
    	
Table 3 
 
Prevalence Rates of Multimorbidities  
  





(M, SD ) 
Black 
(n=249) 
(M, SD ) 
Hispanic 
(n=109) 
(M, SD ) 
p-value 
Number of reported  
diseases 3.12 (1.20) 3.16 (1.22) 2.99 (1.13) 2.97 (1.08) 0.06 
*p < 0.05; **p < 0.01; ***p < 0.001 





Disease factor loadings 
Diseases  Factor 1 Factor 2 Factor 3 Factor 4 
Arthritis -0.08 -0.07 -0.58 -0.05 
Asthma -0.07 0.79 -0.01 -0.1 
Cancers 1 -0.02 0.01 -0.01 
Diabetes -0.18 -0.08 0.32 -0.19 
Emphysema or COPD 0.06 0.65 0.05 0.18 
Hypertension -0.26 -0.23 0.26 -0.18 
Stroke -0.11 -0.05 0.18 0.36 
Ulcers -0.18 -0.01 -0.11 0.34 
Factor name Cancers Pulmonary Metabolic Stress 
Note: factor scores >0.25 are highlighted 





Hierarchical regression analysis of depressive symptoms  
 
Individual Model Hierarchical Regression 
 
Beta SE p-value ΔR2 p-value 
Model 1 
   
0.04 <0.001*** 
Age 0.001 0.050 0.30 
  Gender 0.009 0.001 0.21 
  Race/ethnicity 0.014 0.007 0.01* 
  Marital status -0.014 0.006 0.04* 
  Education -0.019 0.003 <0.001*** 
  Income 0.000 0.000 0.003** 
  Model 2    0.015 <0.001*** 
Age 0.000 0.001 0.422   
Gender 0.009 0.007 0.210   
Race/ethnicity 0.016 0.006 0.005**   
Marital status -0.015 0.007 0.030*   
Education -0.018 0.003 <0.001***   
Income 0.000 0.000 0.003**   
Arthritis 0.022 0.007 0.003**   
Cancers 0.014 0.007 0.052   
Pulmonary factor 0.042 0.014 0.003**   
Metabolic factor 0.012 0.008 0.124   
Stress factor 0.048 0.018 0.008**   
Model 3    0.017 <0.001*** 
Age 0.000 0.001 0.640   
Gender 0.009 0.007 0.221   
Race/ethnicity 0.017 0.006 0.002**   
Marital status -0.015 0.007 0.037*   
Education -0.017 0.003 <0.001***   
Income 0.000 0.000 0.002**   
Arthritis 0.025 0.007 <0.001***   
Cancers 0.017 0.007 0.019*   
Pulmonary factor -0.016 0.021 0.451   
Metabolic factor 0.029 0.018 0.099   
Stress factor 0.000 0.022 0.989   
Hypertension 0.004 0.009 0.657   
Diabetes -0.016 0.016 0.309   
Ulcers 0.015 0.009 0.086   
Stroke 0.033 0.011 0.002**   
Emphysema 0.031 0.011 0.003**   
Asthma 0.035 0.012 0.005**   
53 
Model 4 
   
0.006 <0.001*** 
Age 0.000 0.001 0.73 
  Gender 0.011 0.007 0.14 
  Race/ethnicity 0.017 0.006 0.002** 
  Marital status -0.014 0.007 0.047* 
  Education -0.017 0.003 0.000*** 
  Income 0.000 0.000 0.002** 
  Arthritis factor 0.026 0.007 0.000*** 
  Cancers factor 0.018 0.007 0.014* 
  Pulmonary factor -0.020 0.021 0.33 
  Metabolic factor 0.030 0.018 0.09 
  Stress factor -0.005 0.022 0.84 
  Hypertension 0.004 0.009 0.66 
  Diabetes -0.018 0.016 0.28 
  Ulcers 0.015 0.009 0.08 
  Stroke 0.032 0.011 0.003** 
  Emphysema 0.031 0.010 0.003** 
  Asthma 0.037 0.012 0.003** 
  Cirrhosis 0.037 0.030 0.22 
  Alzheimer's disease 0.039 0.029 0.19 
  Poor kidney 
function 0.045 0.013 0.000*** 
  Thyroid problems 0.001 0.008 0.94     
Change in variance of Model 4 when compared with Model 
1  
(Model 4 ΔR2 – Model 1 ΔR2) 
0.038 <0.001*** 
*p < 0.05; **p < 0.01; ***p < 0.001 




Total number of diseases, as predictive of depressive symptom severity 
Variables Beta SE p-value 
Number of chronic conditions 0.019 0.003 <0.001*** 
Age 0.000 0.001 0.49453 
Gender 0.008 0.007 0.22469 
Ethnicity 0.017 0.006 0.002 ** 
Marital status -0.014 0.007 0.048 * 
Education -0.018 0.003 <0.001*** 
Income 0.000 0.000 0.002** 
*p < 0.05; **p < 0.01; ***p < 0.001     
 
